Genomic Medicine in Emerging Economies
Genomics for Every Nation
Free Global Shipping
No minimum orderDescription
Originally thought to be available only to the world’s wealthiest nations, genomic medicine has developed into a broad range of clinical methods and technologies whose concrete applications are also revolutionizing health systems in many of the world’s resource-limited nations. Genomic Medicine in Emerging Economies: Genomics for Every Nation provides in-depth analysis and key examples of the implementation of medical genomics in low-income nations across the globe, demonstrating how this advancing medical science has already transformed health systems and led to improved patient care in Indonesian, Chilean, Malaysian, Argentinian, Chinese, Sri Lankan, and Colombian populations among others. In addition to defining tools, diagnostics, and treatment pathways at the population-wide level for medical geneticists, genomic researchers, and public health workers to apply in their own work, this book offers an essential, case-study based approach needed to understand how genomic medicine can be used to improve disease-management in a diverse range of economic and social contexts.
Key Features
- Examines essential concepts and protocols, and economic, social and legal considerations related to the implementation of genomic medicine in resource-limited nations
- Features concrete success stories of the implementation of medical genomics in Indonesian, Nepalese, Chilean, Malaysian, Tanzanian, Argentinian, Chinese, Sri Lankan and Columbian populations, amongst others
- Provides tools, diagnostics and treatment pathways for medical geneticists, genomic researchers and public health workers to apply in their own work
- Establishes clear precedents on how genomic technologies can be accessed by nations with limited means and financial support for healthcare
Readership
Human genetics and genomics researchers and students, practitioners of genomic medicine, healthcare professionals, sociologists, and individuals employed in international development, public health, health economics and regulatory bodies around the world
Table of Contents
1. Genomic Medicine in developing and emerging economies: State-of-the-art and future trends
2. Taking genomics from the bench to the bedside in developing countries
3. Genomics and Public Health: China’s Perspective
4. Leveraging International Collaborations to Advance Genomic Medicine in Colombia
5. Screening for hereditary cancer in Latin America
6. Implementing Genomics in the Care of Neuropsychiatric Patients in Latin America
7. Experience in the development of genomics companies during the last 20 years in Argentina
8. Economic evaluation and cost-effectiveness analysis of genomic medicine interventions in developing and emerging countries
9. Raising genomics awareness among the general public and educating healthcare professionals on Genomic Medicine
10. The Genomic Medicine Alliance: A global effort to facilitate the introduction of genomics into healthcare in developing nations
Product details
- No. of pages: 204
- Language: English
- Copyright: © Academic Press 2018
- Published: June 20, 2018
- Imprint: Academic Press
- eBook ISBN: 9780128115510
- Paperback ISBN: 9780128115312
About the Editors
George Patrinos
Dr. George Patrinos is an Associate Professor at the University of Patras School of Health Sciences (Department of Pharmacy) in Patras, Greece with Adjunct positions in Rotterdam, the Netherlands and Al-Ain, United Arab Emirates. His research interests span the fields of molecular diagnostics, high-throughput mutation screening, the development of online mutation diagnostic tools, and the implementation of genomics into healthcare, particularly for health systems in developing countries. George Patrinos has published more than 170 scientific papers in peer reviewed journals on topics related to genetics, genomic medicine, pharmacogenomics, molecular diagnostics, and social and economic evaluation for genomic medicine. Dr. Patrinos is also the co-author of Economic Evaluation in Genomic Medicine (2015) and co-Editor of Molecular Diagnostics, Second Edition (2009), both published by Elsevier, and serves as Communicating Editor for the journal Human Mutation. Additionally, he is co-organizer of the international meeting series “Golden Helix Symposia” and “Golden Helix Pharmacogenomics Days”.
Affiliations and Expertise
Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece; United Arab Emirates University, College of Medicine and Health Sciences, Department of Pathology, Al-Ain, UAE and Erasmus University Medical Center, School of Medicine and Health Sciences, Department of Pathology – Bioinformatics Unit, Rotterdam, The Netherlands
Catalina Lopez-Correa
Dr. Catalina Lopez-Correa MD, PhD is Chief Scientific Officer and Executive Director of the Canadian COVID19 Genomics Network (CanCOGeN) at Genome Canada. Before that she was Chief Operating Officer at Ruta N Medellin. She has 20 years of international experience in genomics in both the academic and private sectors. Before Ruta N, she was Chief Scientific Officer for Genome British Columbia and Genome Quebec and held senior research positions with pharmaceutical giant Eli Lilly and with deCODE genetics in Iceland. As CSO at Genome BC and Genome Quebec she coordinated several initiatives to help understand and address the social, legal, ethical, economical aspects of genomics. Dr. Lopez-Correa has been a national and international champion of equity, diversity, and inclusion in genomics and science in general.
Affiliations and Expertise
Vice-President and CSO, Genome British Columbia
Ratings and Reviews
There are currently no reviews for "Genomic Medicine in Emerging Economies"